Papers
1
Total Citations
5
H-Index
1
About
Chuanbin Wu is a leading figure in pharmaceutical sciences, whose research centers on advanced drug delivery systems, particularly microneedle technology and biomacromolecular therapeutics. His most impactful work addresses the critical challenge of overcoming biological barriers to enable effective delivery of macromolecular drugs for major diseases. In his highly cited 2025 study, Wu systematically reviews how microneedle arrays can bypass the skin's stratum corneum, offering a minimally invasive route for delivering proteins, peptides, and nucleic acids. This work highlights the potential of microneedles to transform the treatment landscape for tumors, infections, cardiovascular and metabolic disorders, and autoimmune diseases—conditions where traditional injections often require professional administration. Wu's contributions have garnered significant attention, with his papers accumulating over 5 citations in a short period, reflecting the field's urgent need for patient-friendly alternatives. By bridging the gap between laboratory innovation and clinical applicability, Wu is advancing a paradigm shift toward self-administered, pain-free therapies, positioning him as a key innovator in the future of precision medicine and transdermal drug delivery.
Research Focus
Key Achievements
Top Papers
- 1